IP Library › Assignment 022024/0105
Patent Assignment
Reel/Frame 022024/0105

Certificate of Merger of Granite Acquisition, Inc. with and into Guilford Pharmaceuticals Inc.

Recorded: 2008-12-23 Pages: 9
Assignors
GRANITE ACQUISITION, INC.
Executed: 2005-10-03
GUILFORD PHARMACEUTICALS INC.
Executed: 2005-10-03
Assignee
MGI GP, INC.
5775 WEST OLD SHAKOPEE ROAD, SUITE 100, BLOOMINGTON, MINNESOTA, 55437
Covered Properties (47)
Methods of Cancer Treatment Using Naaladase Inhibitors
Patent: 5,804,602 →
Application: 08/665,775 →
Certain Phosphonomethyl-Pentanedioic Acid Derivatives Thereof
Patent: 5,672,592 →
Application: 08/665,776 →
Treatment of Global and Focal Ischemia Using Naaladase Inhibitors
Patent: 5,824,662 →
Application: 08/718,703 →
Inhibitors of Naaladase Enzyme Activity
Patent: 5,795,877 →
Application: 08/775,586 →
Phosphoramidate Derivatives
Patent: 5,863,536 →
Application: 08/778,733 →
Hydroxamic Acid Derivatives
Patent: 5,962,521 →
Application: 08/825,997 →
Naaladase Inhibitors
Patent: 5,968,915 →
Application: 08/833,628 →
Naaladase Inhibitors
Patent: 5,880,112 →
Application: 08/833,646 →
Certain Sulfoxide and Sulfone Derivatives
Patent: 5,902,817 →
Application: 08/835,572 →
Phosphonic Acid Derivatives
Patent: 6,054,444 →
Application: 08/842,360 →
Naaladase Inhibitors
Patent: 6,046,180 →
Application: 08/863,624 →
Methods of Cancer Treatment Using Naaladase Inhibitors
Patent: 6,011,021 →
Application: 08/864,545 →
Pharmaceutical Compositions and Methods of Treating a Glutamate Abnormality and Effecting a Neuronal Activity in an Animal Using Naaladase Inhibitors
Patent: 6,017,903 →
Application: 08/884,479 →
Treatment of Global and Focal Ischemia Using Naaladase Inhibitors
Patent: 6,004,946 →
Application: 08/889,358 →
Pharmaceutical Compositions and Methods of Treating Compulsive Disorders Using Naaladase Inhibitors
Patent: 5,977,090 →
Application: 08/899,319 →
Inhibitors of Naaladase Enzyme Activity
Patent: 6,025,345 →
Application: 08/900,194 →
Treatment of Global and Focal Ischemia Using Naaladase Inhibitors
Patent: 5,985,855 →
Application: 08/974,975 →
Use of Naaladase Activity to Identify Prostate Cancer and Benign Prostatic Hyperplasia
Patent: 5,981,209 →
Application: 08/985,121 →
Prodrugs of Naaladase Inhibitors
Patent: 6,384,022 →
Application: 09/001,667 →
Asymmetric Syntheses and Intermediates for Preparing Enantiomer- Enriched Hydroxyphosphinyl Derivatives
Patent: 6,028,216 →
Application: 09/002,146 →
Phosphinic Alkanoic Acid Derivatives
Patent: 6,071,965 →
Application: 09/002,147 →
Phosphinic Acid Derivatives
Patent: 6,121,252 →
Application: 09/050,009 →
Pharmaceutical Compositions and Methods of Inhibiting Angiogenesis Using Naaladase Inhibitors
Patent: 6,395,718 →
Application: 09/110,262 →
Thio-Substituted Pentanedioic Acid Derivatives
Patent: 6,265,609 →
Application: 09/228,391 →
Phosphonic Acid Derivatives
Patent: 6,288,046 →
Application: 09/298,866 →
Hydroxamic Acid Derivatives
Patent: 6,271,245 →
Application: 09/322,688 →
Methods for Treating Anxiety, Anxiety Disorders and Memory Impairment Using Naaladase Inhibitors
Patent: 6,228,888 →
Application: 09/345,782 →
Naaladase Inhibitors Useful as Pharmaceutical Compounds and Compositions
Patent: 6,458,775 →
Application: 09/346,711 →
Metabotropic Glutamate Receptor Ligand Derivatives as Naaladase Inhibitors
Patent: 6,313,159 →
Application: 09/378,443 →
Pharmaceutical Compositions and Methods of Treating a Glutamate Abnormality and Effecting a Neuronal Activity in an Animal Using Naaladase Inhibitors
Patent: 6,413,948 →
Application: 09/388,442 →
Methods of Cancer Treatment Using Naaladase Inhibitors
Patent: 6,372,726 →
Application: 09/405,842 →
Methods for Treating Certain Diseases Using Naaladase Inhibitors
Patent: 6,444,657 →
Application: 09/425,197 →
Sulfonamide Compounds and Medicinal Use Thereof
Patent: 6,348,474 →
Application: 09/446,110 →
Naaladase Inhibitors
Patent: 6,479,471 →
Application: 09/466,059 →
Pharmaceutical Compositions and Methods for Treating Anxiety, Anxiety Disorders and Memory Impairment Using Naaladase Inhibitors
Patent: 6,376,478 →
Application: 09/741,169 →
Benzenedicarboxylic Acid Derivatives
Patent: 6,452,044 →
Application: 09/866,758 →
Publication: US 2002/0019430
Naaladase Inhibitors for Treating Retinal Disorders and Glaucoma
Patent: 7,220,780 →
Application: 09/866,961 →
Publication: US 2003/0036534
Thiol-Based Naaladase Inhibitors
Patent: 6,586,623 →
Application: 10/046,917 →
Publication: US 2003/0105088
Hydroxamic Acids and Acyl Hydroxamines as Naaladase Inhibitors
Patent: 6,884,907 →
Application: 10/141,818 →
Publication: US 2003/0087897
Thiolalkyl Benzoic Acid Derivatives
Patent: 6,740,777 →
Application: 10/156,880 →
Publication: US 2003/0100607
Benzenedicarboxylic Acid Derivatives
Patent: 6,852,750 →
Application: 10/176,046 →
Publication: US 2003/0083505
Methods for Treating Certain Diseases Using Naaladase Inhibitors
Patent: 6,806,261 →
Application: 10/209,011 →
Publication: US 2003/0017965
Thiol-Based Naaladase Inhibitors
Patent: 6,812,364 →
Application: 10/431,462 →
Publication: US 2003/0216468
Indoles as Naaladase Inhibitors
Patent: 7,148,250 →
Application: 10/500,319 →
Publication: US 2005/0080128
Thiolactones
Patent: 7,125,907 →
Application: 10/791,278 →
Publication: US 2005/0004203
Thiolalkyl Benzoic Acid Derivatives
Patent: 7,138,543 →
Application: 10/819,146 →
Publication: US 2004/0198824
Thiol-Based Naaladase Inhibitors
Patent: 6,992,215 →
Application: 10/959,199 →
Publication: US 2005/0085503
Related Assignments (23)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Jan 8, 1997
From: SLUSHER, BARBARA S.; JACKSON, PAUL F.
To: GUILFORD PHARMACEUTICALS INC.
Reel/Frame 008318/0830 →
Assignment of Assignor's Interest Feb 26, 1997
From: JACKSON, PAUL F.; TAYS, KEVIN L.; MACLIN, KEITH M.; SLUSHER, BARBARA S.
To: GUILFORD PHARMACEUTICALS
Reel/Frame 008372/0308 →
Assignment of Assignor's Interest Feb 26, 1997
From: JACKSON, PAUL F.; TAYS, KEVIN L.; MACLIN, KEITH M.; SLUSHER, BARBARA S.
To: GUILFORD PHARMACEUTICALS INC.
Reel/Frame 008380/0916 →
Assignment of Assignor's Interest Apr 7, 1997
From: JACKSON, PAUL F.; SLUSHER, BARBARA S.
To: GUILFORD PHARMACEUTICALS INC.
Reel/Frame 008446/0410 →
Assignment of Assignor's Interest Apr 24, 1997
From: JACKSON, PAUL E.; MACLIN, KEITH M.; TAYS, KEVIN L.; SLUSHER, BARBARA S.
To: GUILFORD PHARMACEUTICALS INC.
Reel/Frame 008509/0001 →
Assignment of Assignor's Interest May 27, 1997
From: JACKSON, PAUL F.; SLUSHER, BARBARA S.; TAYS, KEVIN L.; MACLIN, KEITH M.
To: GUILFORD PHARMACEUTICALS INC
Reel/Frame 008583/0270 →
Assignment of Assignor's Interest May 28, 1997
From: SLUSHER, BARBARA S.; JACKSON, PAUL F.; TAYS, KEVIN L.; MACLIN, KEITH M.
To: GUILFORD PHARMACEUTICALS INC.
Reel/Frame 008584/0610 →
Assignment of Assignor's Interest Nov 18, 1997
From: JACKSON, PAUL F.; TAYS, KEVIN L.; MACLIN, KEITH M.; SLUSHER, BARBARA S.
To: GUILFORD PHARMACEUTICALS INC.
Reel/Frame 008813/0370 →
Assignment of Assignor's Interest Nov 18, 1997
From: SLUSHER, BARBARA S.; JACKSON, PAUL F.; TAYS, KEVIN L.; MACLIN, KEITH M.
To: GUILFORD PHARMACEUTICALS INC.
Reel/Frame 008813/0350 →
Assignment of Assignor's Interest Dec 24, 1997
From: SLUSHER, BARBARA S.; JACKSON, PAUL F.; TAYS, KEVIN L.; MACLIN, KEITH M.
To: GUILFORD PHARMACEUTICALS INC.
Reel/Frame 009121/0740 →
Assignment of Assignor's Interest Jan 2, 1998
From: SLUSHER, BARBARA S.; JACKSON, PAUL F.
To: GUILFORD PHARMACEUTICALS INC.
Reel/Frame 009320/0893 →
Assignment of Assignor's Interest May 11, 1998
From: JACKSON, PAUL F.; TSUKAMOTO, TASKASHI; SLUSHER, BARBARA S.
To: GUILFORD PHARMACEUTICALS INC.
Reel/Frame 009171/0473 →
Assignment of Assignor's Interest May 11, 1998
From: MORALES, GUILLERMO; LI, WEIXING; JACKSON, PAUL F.
To: GUILFORD PHARMACEUTICALS INC.
Reel/Frame 009171/0422 →
Assignment of Assignor's Interest May 11, 1998
From: JACKSON, PAUL F.; LI, WEIXING; MACLIN, KEITH M.; TAYS, KEVIN L.
To: GUILFORD PHARMACEUTICALS INC.
Reel/Frame 009171/0499 →
Assignment of Assignor's Interest May 15, 1998
From: SLUSHER, BARBARA S.; LAPIDUS, RENA S.
To: GUILFORD PHARMACEUTICALS INC.
Reel/Frame 009179/0817 →
Assignment of Assignor's Interest Sep 8, 1998
From: JACKSON, PAUL F.; SLUSHER, BARBARA S.
To: GUILFORD PHARMACEUTICALS INC.
Reel/Frame 009442/0954 →
Assignment of Assignor's Interest Oct 2, 1998
From: SLUSHER, BARBARA S.; LAPIDUS, RENA S.
To: GUILFORD PHARMACEUTICALS, INC.
Reel/Frame 009501/0713 →
Assignment of Assignor's Interest Feb 11, 1999
From: JACKSON, PAUL F.; SLUSHER, BARBATA S.; TAYS, KEVIN L.; MACLIN, KEITH M.
To: GUILFORD PHARMACEUICALS, INC.
Reel/Frame 009755/0802 →
Assignment of Assignor's Interest Apr 16, 1999
From: JACKSON, PAUL F.; TSUKAMOTO, TAKASHI; KO, YAO-SEN; SLUSHER, BARBARA S.
To: GUILFORD PHARMACEUTICALS INC.
Reel/Frame 009897/0313 →
Assignment of Assignor's Interest Apr 19, 1999
From: JACKSON, PAUL F.; MACLIN, KEITH M.; WANG, ERIC; SLUSHER, BARBARA S.
To: GUILFORD PHARMACEUTICALS INC.
Reel/Frame 009895/0705 →
Assignment of Assignor's Interest Jul 23, 1999
From: SLUSHER, BARABARA S.; JACKSON, PAUL F.
To: GUILFORD PHARMACEUTICALS INC.
Reel/Frame 010114/0765 →
Assignment of Assignor's Interest Feb 19, 2009
From: MGI GP, INC.
To: EISAI CORPORATION OF NORTH AMERICA
Reel/Frame 022277/0779 →
Assignment of Assignor's Interest Dec 24, 2009
From: EISAI CORPORATION OF NORTH AMERICA
To: EISAI INC.
Reel/Frame 023699/0188 →